The Solution: dtb-instilla (direct-to-bladder) Targeted Therapy
The dtb-instillaTM is a drug delivery system that consists of a single-use disposable device that dispenses a precise dose of the medication directly into the bladder.
UroPharma’s patented technologies, coupled with generic and new drug combinations, directly target the urinary bladder rather than exposing the entire body to the medications.
This overcomes many of the shortcomings of current approaches to treat bladder and lower urinary tract afflictions.
Through the integration of its unique drug-delivery system, dtb-instilla along with its novel pharmaceutical therapies, UroPharma’s technology is fixed on:
Improving the quality of care for patients.
Reducing the risk of urinary tract infections.
Reducing total costs for payers and providers.